Koa Wealth Management’s Avidity Biosciences RNAM Stock Holding History

Koa Wealth Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,000	Closed	-$361K	–	59
2025 Q4	$361K	Hold	5,000	–	–	0.25%	50
2025 Q3	$218K	Buy	+5,000	New	+$202K	0.16%	53
2024 Q4	–	Sell	-5,000	Closed	-$230K	–	52
2024 Q3	$230K	Sell	5,000 -3,000	-38%	-$130K	0.18%	46
2024 Q2	$327K	Hold	8,000	–	–	0.28%	41
2024 Q1	$204K	Sell	8,000 -2,000	-20%	-$31.3K	0.18%	47
2023 Q4	$90.5K	Buy	+10,000	New	+$66.8K	0.09%	48

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Koa Wealth Management's RNAM Position: Q1 2026 in Review

Koa Wealth Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 5,000 shares — an estimated $361K sold.

Koa Wealth Management first reported a position in RNAM in Q4 2023 and held it in 6 quarters. The position peaked at $361K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Koa Wealth Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Koa Wealth Management sold 5,000 Avidity Biosciences shares in Q1 2026, an estimated $361K.
Koa Wealth Management first reported a position in Avidity Biosciences in Q4 2023 and held it in 6 quarters.
Koa Wealth Management's Avidity Biosciences position peaked at $361K in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Koa Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.